EFFICACY ANALYSIS OF CANNABIDIOL IN AUTISM SPECTRUM DISORDER: integrative review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Brazilian Journal of Implantology and Health Sciences |
Texto Completo: | https://bjihs.emnuvens.com.br/bjihs/article/view/1066 |
Resumo: | Introduction: Autism Spectrum Disorder (ASD) is characterized as a neurological condition with complex causes, potentially affecting social interactions and manifesting repetitive behaviors. Cannabidiol (CBD), a non-intoxicating component of the cannabis plant, shows therapeutic potential for relieving these symptoms safely and with minimal side effects, thereby improving the quality of life and daily functioning in individuals with ASD. Objective: This systematic review aims, through controlled studies, case reports, and reviews, to understand and describe the benefits and drawbacks of the relationship between individuals with ASD and the therapeutic use of CBD. Methodology: In this literature review, descriptors in Portuguese, English, and Spanish were used for bibliographic searches on databases such as Google Scholar, SciELO, PubMed, and BVS in September 2023. Inclusion criteria restricted articles to the last 5 years, published in Portuguese or English. Out of the initially identified 277 articles, 20 were selected. Results: The findings highlight improvements in social interaction, behavioral symptoms, and sleep quality with the use of CBD. However, there are reports of adverse effects such as drowsiness and decreased appetite, yet the majority of studies deem CBD to be safe. Conclusion: The research emphasizes the lack of a specific pharmacological treatment for ASD but underscores the importance of CBD as a complementary therapy, given the notable benefits and mild complications observed with the use of this substance. It further highlights the need for more medical and scientific research to better understand the effectiveness and potential adverse effects of CBD therapy in ASD. |
id |
GOE-1_6aba6abb32460ab19fe8973c6e401e85 |
---|---|
oai_identifier_str |
oai:ojs.bjihs.emnuvens.com.br:article/1066 |
network_acronym_str |
GOE-1 |
network_name_str |
Brazilian Journal of Implantology and Health Sciences |
repository_id_str |
|
spelling |
EFFICACY ANALYSIS OF CANNABIDIOL IN AUTISM SPECTRUM DISORDER: integrative reviewANÁLISE DA EFICÁCIA DO CANABIDIOL NO TRANSTORNO DO ESPECTRO AUTISTA: revisão integrativaTranstorno do Espectro AutistaCanabidiol (CBD)terapia complementarIntroduction: Autism Spectrum Disorder (ASD) is characterized as a neurological condition with complex causes, potentially affecting social interactions and manifesting repetitive behaviors. Cannabidiol (CBD), a non-intoxicating component of the cannabis plant, shows therapeutic potential for relieving these symptoms safely and with minimal side effects, thereby improving the quality of life and daily functioning in individuals with ASD. Objective: This systematic review aims, through controlled studies, case reports, and reviews, to understand and describe the benefits and drawbacks of the relationship between individuals with ASD and the therapeutic use of CBD. Methodology: In this literature review, descriptors in Portuguese, English, and Spanish were used for bibliographic searches on databases such as Google Scholar, SciELO, PubMed, and BVS in September 2023. Inclusion criteria restricted articles to the last 5 years, published in Portuguese or English. Out of the initially identified 277 articles, 20 were selected. Results: The findings highlight improvements in social interaction, behavioral symptoms, and sleep quality with the use of CBD. However, there are reports of adverse effects such as drowsiness and decreased appetite, yet the majority of studies deem CBD to be safe. Conclusion: The research emphasizes the lack of a specific pharmacological treatment for ASD but underscores the importance of CBD as a complementary therapy, given the notable benefits and mild complications observed with the use of this substance. It further highlights the need for more medical and scientific research to better understand the effectiveness and potential adverse effects of CBD therapy in ASD. Introdução: O Transtorno do Espectro Autista (TEA) é caracterizado como uma condição neurológica com causas complexas, podendo afetar as interações sociais e manifestar comportamentos repetitivos. O Canabidiol (CBD), componente não intoxicante da planta cannabis, apresenta um potencial terapêutico para o alivio desses sintomas de forma segura e com baixos efeitos colaterais, melhorando a qualidade de vida e o funcionamento diário em pessoas com TEA. Objetivo: Esta revisão sistemática tem como objetivo, a partir de estudos controlados, relatos de casos e revisões, entender e descrever os benefícios e os malefícios da relação entre os pacientes com TEA e o uso terapêutico do CBD. Metodologia: Nesta revisão de literatura, foram utilizados descritores em português, inglês e espanhol para a busca bibliográfica em bases de dados como Google Scholar, SciELO, PubMed e BVS, no período de setembro de 2023. Os critérios de inclusão limitaram os artigos aos últimos 5 anos, publicados em português ou inglês. Dos 277 artigos inicialmente identificados, 20 foram selecionados. Resultados: Os resultados evidenciam melhorias na interação social, nos sintomas comportamentais e na qualidade do sono com o uso de CBD. No entanto, há relatos de efeitos adversos, como sonolência e diminuição do apetite, mas, a maioria dos estudos consideram o CBD seguro. Conclusão: A pesquisa destaca a falta de tratamento farmacológico específico para o TEA, porém enfatiza a importância do CBD como terapia complementar, visto que é observado benefícios notáveis e complicações leves no uso dessa substância. Ressalta-se ainda a necessidade de mais pesquisas médicas e científicas para compreender melhor a eficácia e os possíveis efeitos adversos da terapia com CBD no TEA. Specialized Dentistry Group2023-12-19info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://bjihs.emnuvens.com.br/bjihs/article/view/106610.36557/2674-8169.2023v5n5p5859-5873Brazilian Journal of Implantology and Health Sciences ; Vol. 5 No. 5 (2023): BJIHS QUALIS B3; 5859-5873Brazilian Journal of Implantology and Health Sciences ; Vol. 5 Núm. 5 (2023): BJIHS QUALIS B3; 5859-5873Brazilian Journal of Implantology and Health Sciences ; v. 5 n. 5 (2023): BJIHS QUALIS B3; 5859-58732674-8169reponame:Brazilian Journal of Implantology and Health Sciencesinstname:Grupo de Odontologia Especializada (GOE)instacron:GOEporhttps://bjihs.emnuvens.com.br/bjihs/article/view/1066/1265Copyright (c) 2023 Paloma Lara Ferreira Silva, Natália de Fátima Gonçalves Amâncio, Vanessa Pereira Tolentinohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSilva, Paloma Lara FerreiraAmâncio, Natália de Fátima Gonçalves Pereira Tolentino, Vanessa2023-12-19T11:04:16Zoai:ojs.bjihs.emnuvens.com.br:article/1066Revistahttps://bjihs.emnuvens.com.br/bjihsONGhttps://bjihs.emnuvens.com.br/bjihs/oaijournal.bjihs@periodicosbrasil.com.br2674-81692674-8169opendoar:2023-12-19T11:04:16Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE)false |
dc.title.none.fl_str_mv |
EFFICACY ANALYSIS OF CANNABIDIOL IN AUTISM SPECTRUM DISORDER: integrative review ANÁLISE DA EFICÁCIA DO CANABIDIOL NO TRANSTORNO DO ESPECTRO AUTISTA: revisão integrativa |
title |
EFFICACY ANALYSIS OF CANNABIDIOL IN AUTISM SPECTRUM DISORDER: integrative review |
spellingShingle |
EFFICACY ANALYSIS OF CANNABIDIOL IN AUTISM SPECTRUM DISORDER: integrative review Silva, Paloma Lara Ferreira Transtorno do Espectro Autista Canabidiol (CBD) terapia complementar |
title_short |
EFFICACY ANALYSIS OF CANNABIDIOL IN AUTISM SPECTRUM DISORDER: integrative review |
title_full |
EFFICACY ANALYSIS OF CANNABIDIOL IN AUTISM SPECTRUM DISORDER: integrative review |
title_fullStr |
EFFICACY ANALYSIS OF CANNABIDIOL IN AUTISM SPECTRUM DISORDER: integrative review |
title_full_unstemmed |
EFFICACY ANALYSIS OF CANNABIDIOL IN AUTISM SPECTRUM DISORDER: integrative review |
title_sort |
EFFICACY ANALYSIS OF CANNABIDIOL IN AUTISM SPECTRUM DISORDER: integrative review |
author |
Silva, Paloma Lara Ferreira |
author_facet |
Silva, Paloma Lara Ferreira Amâncio, Natália de Fátima Gonçalves Pereira Tolentino, Vanessa |
author_role |
author |
author2 |
Amâncio, Natália de Fátima Gonçalves Pereira Tolentino, Vanessa |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Silva, Paloma Lara Ferreira Amâncio, Natália de Fátima Gonçalves Pereira Tolentino, Vanessa |
dc.subject.por.fl_str_mv |
Transtorno do Espectro Autista Canabidiol (CBD) terapia complementar |
topic |
Transtorno do Espectro Autista Canabidiol (CBD) terapia complementar |
description |
Introduction: Autism Spectrum Disorder (ASD) is characterized as a neurological condition with complex causes, potentially affecting social interactions and manifesting repetitive behaviors. Cannabidiol (CBD), a non-intoxicating component of the cannabis plant, shows therapeutic potential for relieving these symptoms safely and with minimal side effects, thereby improving the quality of life and daily functioning in individuals with ASD. Objective: This systematic review aims, through controlled studies, case reports, and reviews, to understand and describe the benefits and drawbacks of the relationship between individuals with ASD and the therapeutic use of CBD. Methodology: In this literature review, descriptors in Portuguese, English, and Spanish were used for bibliographic searches on databases such as Google Scholar, SciELO, PubMed, and BVS in September 2023. Inclusion criteria restricted articles to the last 5 years, published in Portuguese or English. Out of the initially identified 277 articles, 20 were selected. Results: The findings highlight improvements in social interaction, behavioral symptoms, and sleep quality with the use of CBD. However, there are reports of adverse effects such as drowsiness and decreased appetite, yet the majority of studies deem CBD to be safe. Conclusion: The research emphasizes the lack of a specific pharmacological treatment for ASD but underscores the importance of CBD as a complementary therapy, given the notable benefits and mild complications observed with the use of this substance. It further highlights the need for more medical and scientific research to better understand the effectiveness and potential adverse effects of CBD therapy in ASD. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-12-19 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://bjihs.emnuvens.com.br/bjihs/article/view/1066 10.36557/2674-8169.2023v5n5p5859-5873 |
url |
https://bjihs.emnuvens.com.br/bjihs/article/view/1066 |
identifier_str_mv |
10.36557/2674-8169.2023v5n5p5859-5873 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://bjihs.emnuvens.com.br/bjihs/article/view/1066/1265 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Specialized Dentistry Group |
publisher.none.fl_str_mv |
Specialized Dentistry Group |
dc.source.none.fl_str_mv |
Brazilian Journal of Implantology and Health Sciences ; Vol. 5 No. 5 (2023): BJIHS QUALIS B3; 5859-5873 Brazilian Journal of Implantology and Health Sciences ; Vol. 5 Núm. 5 (2023): BJIHS QUALIS B3; 5859-5873 Brazilian Journal of Implantology and Health Sciences ; v. 5 n. 5 (2023): BJIHS QUALIS B3; 5859-5873 2674-8169 reponame:Brazilian Journal of Implantology and Health Sciences instname:Grupo de Odontologia Especializada (GOE) instacron:GOE |
instname_str |
Grupo de Odontologia Especializada (GOE) |
instacron_str |
GOE |
institution |
GOE |
reponame_str |
Brazilian Journal of Implantology and Health Sciences |
collection |
Brazilian Journal of Implantology and Health Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE) |
repository.mail.fl_str_mv |
journal.bjihs@periodicosbrasil.com.br |
_version_ |
1796798442192764928 |